Beschreibung:
<jats:title>Summary</jats:title><jats:p>At ASCO 2022 several studies were presented. This short review is about hepatocellular carcinoma, and cholangiocellular carcinoma and trials like STAMP, ImmunoTACE trial, FOENIX-CCA2, ImmunoTACE trial, for example.</jats:p>